SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Wood DM, Dargan PI. Putting cocaine use and cocaine-associated cardiac arrhythmias into epidemiological and clinical perspective. Br J Clin Pharmacol 2010; 69: 4437.
  • 2
    Mittleman RE, Wetli CV. Cocaine and sudden ‘natural’ death. J Forensic Sci 1987; 32: 119.
  • 3
    Mehta A, Jain AC, Mehta MC. Electrocardiographic effects of intravenous cocaine: an experimental study in a canine model. J Cardiovasc Pharmacol 2003; 41: 2530.
  • 4
    O'Leary ME, Hancox JC. Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated arrhythmias. Br J Clin Pharmacol 2010; 69: 42742.
  • 5
    Macedo T, Ribeiro CA, Cotrim D, Tavares P, Morgadinho MT, Caramona M, Vicente MT, Rodrigues L, Cardoso MG, Keating ML. Catecholamine and MHPG plasma levels, platelet MAO activity, and 3H-imipramine binding in heroin and cocaine addicts. Mol Neurobiol 1995; 11: 219.
  • 6
    Hollander JE, Hoffman RS. Cocaine-induced myocardial infarction: an analysis and review of the literature. J Emerg Med 1992; 10: 16977.
  • 7
    Hollander JE, Hoffman RS, Burstein JL, Shih RD, Thode HC Jr. Cocaine-associated myocardial infarction. Mortality and complications. Cocaine-Associated Myocardial Infarction Study Group. Arch Intern Med 1995; 155: 10816.
  • 8
    Nelson LS. Toxicologic myocardial sensitization. J Toxicol Clin Toxicol 2002; 40: 86779.
  • 9
    Vaughan Williams EM. A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 1984; 24: 12947.
  • 10
    Starmer CF, Grant AO, Strauss HC. Mechanisms of use-dependent block of sodium channels in excitable membranes by local anesthetics. Biophys J 1984; 46: 1527.
  • 11
    Wang RY. pH-dependent cocaine-induced cardiotoxicity. Am J Emerg Med 1999; 17: 3649.
  • 12
    Niemann JT, Bessen HA, Rothstein RJ, Laks MM. Electrocardiographic criteria for tricyclic antidepressant cardiotoxicity. Am J Cardiol 1986; 57: 11549.
  • 13
    Brugada P, Brugada J, Mont L, Smeets J, Andries EW. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation 1991; 83: 164959.
  • 14
    Chakko S, Sepulveda S, Kessler KM, Sotomayor MC, Mash DC, Prineas RJ, Myerburg RJ. Frequency and type of electrocardiographic abnormalities in cocaine abusers (electrocardiogram in cocaine abuse). Am J Cardiol 1994; 74: 7103.
  • 15
    Littmann L, Monroe MH, Svenson RH. Brugada-type electrocardiographic pattern induced by cocaine. Mayo Clin Proc 2000; 75: 8459.
  • 16
    Bebarta VS, Summers S. Brugada electrocardiographic pattern induced by cocaine toxicity. Ann Emerg Med 2007; 49: 8279.
  • 17
    Ortega-Carnicer J, Bertos-Polo J, Gutierrez-Tirado C. Aborted sudden death, transient Brugada pattern, and wide QRS dysrrhythmias after massive cocaine ingestion. J Electrocardiol 2001; 34: 3459.
  • 18
    Schwartz AB, Janzen D, Jones RT, Boyle W. Electrocardiographic and hemodynamic effects of intravenous cocaine in awake and anesthetized dogs. J Electrocardiol 1989; 22: 15966.
  • 19
    Beckman KJ, Parker RB, Hariman RJ, Gallastegui JL, Javaid JI, Bauman JL. Hemodynamic and electrophysiological actions of cocaine. Effects of sodium bicarbonate as an antidote in dogs. Circulation 1991; 83: 1799807.
  • 20
    Winecoff AP, Hariman RJ, Grawe JJ, Wang Y, Bauman JL. Reversal of the electrocardiographic effects of cocaine by lidocaine. Part 1. Comparison with sodium bicarbonate and quinidine. Pharmacotherapy 1994; 14: 698703.
  • 21
    Whitcomb DC, Gilliam FR III, Starmer CF, Grant AO. Marked QRS complex abnormalities and sodium channel blockade by propoxyphene reversed with lidocaine. J Clin Invest 1989; 84: 162936.
  • 22
    Dolara P, Franconi F. Hypertonic sodium chloride and lidocaine in a case of imipramine intoxication. Clin Toxicol 1977; 10: 3958.
  • 23
    Jensen AM. Amitriptyline poisoning with severe cardiac arrhythmia treated with lidocaine. Ugeskr Laeger 1970; 132: 98100.
  • 24
    Kerns W II, Garvey L, Owens J. Cocaine-induced wide complex dysrhythmia. J Emerg Med 1997; 15: 3219.
  • 25
    Jonsson S, O'Meara M, Young JB. Acute cocaine poisoning. Importance of treating seizures and acidosis. Am J Med 1983; 75: 10614.
  • 26
    Derlet RW, Albertson TE, Tharratt RS. Lidocaine potentiation of cocaine toxicity. Ann Emerg Med 1991; 20: 1358.
  • 27
    Heit J, Hoffman RS, Goldfrank LR. The effects of lidocaine pretreatment on cocaine neurotoxicity and lethality in mice. Acad Emerg Med 1994; 1: 43842.
  • 28
    Grawe JJ, Hariman RJ, Winecoff AP, Fischer JH, Bauman JL. Reversal of the electrocardiographic effects of cocaine by lidocaine. Part 2. Concentration-effect relationships. Pharmacotherapy 1994; 14: 70411.
  • 29
    Shih RD, Hollander JE, Burstein JL, Nelson LS, Hoffman RS, Quick AM. Clinical safety of lidocaine in patients with cocaine-associated myocardial infarction. Ann Emerg Med 1995; 26: 7026.
  • 30
    Smilkstein MJ. Reviewing cyclic antidepressant cardiotoxicity: wheat and chaff. J Emerg Med 1990; 8: 6458.
  • 31
    Parker RB, Perry GY, Horan LG, Flowers NC. Comparative effects of sodium bicarbonate and sodium chloride on reversing cocaine-induced changes in the electrocardiogram. J Cardiovasc Pharmacol 1999; 34: 8649.
  • 32
    DeWitt CR, Cleveland N, Dart RC, Heard K. The effect of amiodarone pretreatment on survival of mice with cocaine toxicity. J Med Toxicol 2005; 1: 118.
  • 33
    Baumann BM, Perrone J, Hornig SE, Shofer FS, Hollander JE. Randomized, double-blind, placebo-controlled trial of diazepam, nitroglycerin, or both for treatment of patients with potential cocaine-associated acute coronary syndromes. Acad Emerg Med 2000; 7: 87885.
  • 34
    Honderick T, Williams D, Seaberg D, Wears R. A prospective, randomized, controlled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in the treatment of cocaine-associated acute coronary syndromes (see comment). Am J Emerg Med 2003; 21: 3942.
  • 35
    Albertson TE, Dawson A, De Latorre F, Hoffman RS, Hollander JE, Jaeger A, Kerns WR 2nd, Martin TG, Ross MP, American Heart Association, International Liaison Committee on Resuscitation. TOX-ACLS: toxicologic-oriented advanced cardiac life support. Ann Emerg Med 2001; 4 (Suppl.): S7890.
  • 36
    Hoffman RS. Cocaine and beta-blockers: should the controversy continue? Ann Emerg Med 2008; 51: 1279.
  • 37
    Kimura S, Bassett AL, Xi H, Myerburg RJ. Early afterdepolarizations and triggered activity induced by cocaine. A possible mechanism of cocaine arrhythmogenesis. Circulation 1992; 85: 222735.
  • 38
    Gamouras GA, Monir G, Plunkitt K, Gursoy S, Dreifus LS. Cocaine abuse: repolarization abnormalities and ventricular arrhythmias. Am J Med Sci 2000; 320: 912.
  • 39
    Singh N, Singh HK, Singh PP, Khan IA. Cocaine-induced torsades de pointes in idiopathic long Q-T syndrome. Am J Ther 2001; 8: 299302.
  • 40
    Schrem SS, Belsky P, Schwartzman D, Slater W. Cocaine-induced torsades de pointes in a patient with the idiopathic long QT syndrome. Am Heart J 1990; 120: 9804.
  • 41
    Riaz K, McCullough PA. Fatal case of delayed repolarization due to cocaine abuse and global ischemia. Rev Cardiovasc Med 2003; 4: 4753.
  • 42
    Perera R, Kraebber A, Schwartz MJ. Prolonged QT interval and cocaine use. J Electrocardiol 1997; 30: 3379.
  • 43
    Krantz MJ, Rowan SB, Mehler PS. Cocaine-related torsade de pointes in a methadone maintenance patient. J Addict Dis 2005; 24: 5360.
  • 44
    Taylor D, Parish D, Thompson L, Cavaliere M. Cocaine induced prolongation of the QT interval. Emerg Med J 2004; 21: 2523.
  • 45
    Chan A, Isbister GK, Kirkpatrick CM, Dufful SB. Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. QJM 2007; 100: 60915.
  • 46
    Nahas GG, Trouve R, Manger WM. Cocaine, catecholamines and cardiac toxicity. Acta Anaesthesiol Scand Suppl 1990; 94: 7781.
  • 47
    Trouve R, Nahas GG, Manger WM. Catecholamines, cocaine toxicity, and their antidotes in the rat. Proc Soc Exp Biol Med 1991; 196: 1847.
  • 48
    Sloan MA, Mattioni TA. Concurrent myocardial and cerebral infarctions after intranasal cocaine use. Stroke 1992; 23: 42730.
  • 49
    Merigian KS. Cocaine-induced ventricular arrhythmias and rapid atrial fibrillation temporally related to naloxone administration. Am J Emerg Med 1993; 11: 967.
  • 50
    Greenblatt DJ, Ehrenberg BL, Gunderman J, Scavone JM, Tai NT, Harmatz JS, Shader RI. Kinetic and dynamic study of intravenous lorazepam: comparison with intravenous diazepam. J Pharmacol Exp Ther 1989; 250: 13440.
  • 51
    Greenblatt DJ, Ehrenberg BL, Gunderman J, Locniskar A, Scavone JM, Harmatz JS, Shader RI. Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo. Clin Pharmacol Ther 1989; 45: 35665.
  • 52
    Greenblatt DJ, Joyce TH, Comer WH, Knowles JA, Shader RI, Kyriakopoulos AA, MacLaughlin DS, Ruelius HW. Clinical pharmacokinetics of lorazepam. II. Intramuscular injection. Clin Pharmacol Ther 1977; 21: 22230.
  • 53
    Wermeling DP, Miller JL, Archer SM, Manaligod JM, Rudy AC. Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous, and intramuscular administration. J Clin Pharmacol 2001; 41: 122531.
  • 54
    Hung OR, Dyck JB, Varvel J, Shafer SL, Stanski DR. Comparative absorption kinetics of intramuscular midazolam and diazepam. Can J Anaesth 1996; 43 (5 Pt 1): 4505.
  • 55
    Watson DM, Uden DL. Promotion of intramuscular diazepam questioned. Am J Hosp Pharm 1981; 38: 968, 970–1.
  • 56
    Divoll M, Greenblatt DJ, Ochs HR, Shader RI. Absolute bioavailability of oral and intramuscular diazepam: effects of age and sex. Anesth Analg 1983; 62: 18.
  • 57
    Guinn MM, Bedford JA, Wilson MC. Antagonism of intravenous cocaine lethality in nonhuman primates. Clin Toxicol 1980; 16: 499508.
  • 58
    Catravas JD, Waters IW. Acute cocaine intoxication in the conscious dog: studies on the mechanism of lethality. J Pharmacol Exp Ther 1981; 217: 3506.
  • 59
    Lange RA, Cigarroa RG, Flores ED, McBride W, Kim AS, Wells PJ, Bedotto JB, Danziger RS, Hillis LD. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med 1990; 112: 897903.
  • 60
    Sand IC, Brody SL, Wrenn KD, Slovis CM. Experience with esmolol for the treatment of cocaine-associated cardiovascular complications. Am J Emerg Med 1991; 9: 1613.
  • 61
    Fareed FN, Chan G, Hoffman RS. Death temporally related to the use of a beta adrenergic receptor antagonist in cocaine associated myocardial infarction. J Med Toxicol 2007; 3: 16972.
  • 62
    McCord J, Jneid H, Hollander JE, De Lemos JA, Cercek B, Hsue P, Gibler WB, Ohman EM, Drew B, Philippides G, Newby LK, American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation 2008; 117: 1897907.
  • 63
    Hollander JE. The management of cocaine-associated myocardial ischemia. N Engl J Med 1995; 333: 126772.
  • 64
    Isner JM, Estes NA III, Thompson PD, Costanzo-Nordin MR, Subramanian R, Miller G, Katsas G, Sweeney K, Sturner WQ. Acute cardiac events temporally related to cocaine abuse. N Engl J Med 1986; 315: 143843.
  • 65
    Billman GE. Effect of calcium channel antagonists on cocaine-induced malignant arrhythmias: protection against ventricular fibrillation. J Pharmacol Exp Ther 1993; 266: 40716.
  • 66
    Billman GE, Hoskins RS. Cocaine-induced ventricular fibrillation: protection afforded by the calcium antagonist verapamil. FASEB J 1988; 2: 29905.
  • 67
    Billman GE. The effect of adrenergic receptor antagonists on cocaine-induced ventricular fibrillation: alpha but not beta adrenergic receptor antagonists prevent malignant arrhythmias independent of heart rate. J Pharmacol Exp Ther 1994; 269: 40916.
  • 68
    Lange RA, Cigarroa RG, Yancy CW Jr, Willard JE, Popma JJ, Sills MN, McBride W, Kim AS, Hillis LD. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med 1989; 321: 155762.
  • 69
    Chan GM, Sharma R, Price D, Hoffman RS, Nelson LS. Phentolamine therapy for cocaine- association acute coronary syndrome (CAACS). J Med Toxicol 2006; 2: 10811.
  • 70
    Hollander JE, Carter WA, Hoffman RS. Use of phentolamine for cocaine-induced myocardial ischemia. N Engl J Med 1992; 327: 361.